Urology Reconstruction Meshes Market - Introduction
Surgical mesh is a thin material used for tissue reinforcement. Biopolymers and synthetic polymers are used to manufacture surgical meshes. Materials used to manufacture surgical meshes include polypropylene, polycaprolactone, and acellular collagen. Surgical meshes are used to treat stress urinary incontinence and pelvic organ prolapse in woman, and in men it is used for hernia repair. Transvaginal insertion and transabdominal insertion of mesh are the procedures utilized to treat pelvic organ prolapse. Moreover, mesh slings are used to treat stress urinary incontinence.
Urology Reconstruction Meshes Market – Competitive Landscape
The global urology reconstruction meshes market is highly fragmented due to the presence of large number of players. A large number of manufacturers hold prominent market shares in their respective regions. Futura Surgicare Pvt. Ltd., a manufacturer in India, offers Dolphin Mesh for laparoscopic tension-free hernia repair. KOLLSUT offers surgical sutures and hernia mesh. The company distributes products across Italy, Iraq, and Azerbaijan through AIESI Hospital Service S.A.S., MultiMedical Lebanon SARL, and SET MEDICAL LLC, respectively.
Acquisition, product launch among key players is likely augment the global urology reconstruction meshes market.
Identify the key factors that will drive your company’s growth, Request a brochure of this report here
Boston Scientific Corporation (AMS)
Founded in 1960, headquarter in Marlborough, U.S. Boston Scientific Corporation is engaged in the development, manufacture, and marketing of medical devices that are utilized in interventional medical specialties. The company operates through three reportable business segments: cardiovascular, rhythm management, and MedSurg. The MedSurg segment offers products for endoscopy, urology & pelvic health, and neuromodulator.
Becton Dickinson & Company (C. R. Bard),
Incorporated in 1897, headquarter in New Jersey, U.S. C. R. Bard is a leading company that designs, develops, manufactures, packages, distributes, and sells surgical, medical, patient care devices, and diagnostic. It provides a wide range of products to hospitals, individual health care professionals, extended care health facilities, and alternate site facilities on a global basis. The company offers the product for urology, vascular, oncology, and surgical specialty under the BD Interventional segment. In 2018, company launched BD Interventional segment with urological products portfolio. In April 2017, Becton, Dickinson acquired C. R. Bard. This acquisition enabled the company to achieve leadership in medication management and infection prevention, thereby enhancing growth opportunities for the combined company in the non-U.S. markets.
- Braun Melsungen AG
Established in 1839, headquarter in Tuttlingen, Germany. B. Braun Melsungen AG is a leading manufacturer of medical technology and pharmaceutical products as well as provider of medical services. The company operates through major four divisions: Aesculap, Avitum, Hospital Care, and Out-patient Market.
Founded in 1949. Medtronic headquarter in Dublin, Ireland. Medtronic is a leading medical devices company that develops, manufactures, and markets products for alleviating pain and restoring normal health of patients. The company operates through four business segments: cardiac & vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. In March 2014, Medtronic plc launched Symbotex composite mesh in the U.S. for the treatment of open ventral hernia repair. It is dual sided mesh which is made from macrospores monofilament mesh. This product launched enabled to broaden the choice of surgeon for the treatment of hernia repair.
Coloplast Corp founded in 1978. It is one of the leading players engaged in developing and manufacturing the products for wound care, skin care and urology interventional products.
Expanding operations in future? To get the perfect launch ask for a custom report here
Urology Reconstruction Meshes Market – Dynamics
Driver - Rising prevalence of Urinary Incontinence & Hernia Repair
Urinary tract infection, obstruction, pregnancy, and constipation etc. leading to urinary incontinence. According to the World Health Organization (WHO), prevalence of urinary incontinence is higher among older men and women. Furthermore, increase in number of hernia repair procedures is likely propel the growth of the market. An article published in Visceral Medicine stated that an estimated 20 million patients undergo hernia repair procedure across the worldwide each year.
Restrain – Complication Associated with Mesh & Product Recall
Urinary problems, infection and bleeding are the complications associated with the surgical meshes. For instance, In April 2019, the Food and Drug Administration ordered to stop the sale and distribution of surgical meshes for pelvic organ prolapse in the U.S. due to safety concerns among women.
Urology Reconstruction Meshes Market – Segmentation
The urology reconstruction meshes market can be bifurcated on the basis of: material, application, and region.
In terms of material, the urology reconstruction meshes market can be divided into:
- Absorbable synthetic polymer
- Non-absorbable synthetic polymer
Based on application, the urology reconstruction meshes market can be fragmented into:
- Pelvic organ prolapse
- Hernia repair
- Stress urinary incontinence
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.